XBiotech hatches big plans for Austin campus

Austin-based antibody-developer XBiotech has hatched some big plans for a $200 million campus that would ultimately employ some 2,000 people, according to the Austin Business Journal. The development-stage company has raised about $50 million so far and is looking for some incentives to get the project under way. Back in March, the company got a green light to launch a mid-stage study of an antibody for cachexia. Story

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.